Idexx Laboratories ( (IDXX) ) has shared an update. Jonathan W. Ayers, former Chairman and CEO of IDEXX Laboratories, has resigned from the ...

Shares of IDEXX Laboratories Inc. IDXX inched 0.06% higher to $433.28 Friday, on what proved to be an all-around great ...

Idexx Laboratories reported a strong earnings beat for Q3 2024, but reduced its revenue guidance. Idexx Laboratories, a global leader in veterinary diagnostics, focuses on providing a wide range ...

Idexx Laboratories ( (IDXX) ) has released its Q3 earnings. Here is a breakdown of the information Idexx Laboratories presented to its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Animal diagnostic and health care company posted revenue of $975.5 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $979.6 million. Idexx ...

Idexx delivered another quarter of unusually muted companion animal growth (up 7% year over year) and lowered management outlook again, sending shares swooning 9% in premarket trading. We have ...

Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth Idexx Laboratories posted a Q3 EPS of $2.79, beating estimates ...

Barclays lowered the firm’s price target on Idexx Laboratories (IDXX) to $481 from $570 and keeps an Overweight rating on the shares. The firm sees the softer visit trends continuing based on ...

Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Idexx Laboratories (IDXX) reports results for the quarter ended September 2024. While this widely-known consensus ...